Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2006
08/24/2006WO2004094374A3 Preparation of (s)-clopidogrel and related compounds
08/24/2006US20060189674 Deacetylase inhibitors
08/24/2006US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection
08/24/2006US20060189664 Diphenylpyridine derivatives, preparation and therapeutic application thereof
08/24/2006US20060189663 Pyrrole-2,5-dithione derivatives as liver x receptor modulators
08/24/2006US20060189650 Novel piperidine derivatives as modulators of chemokine receptor ccr5
08/24/2006US20060189647 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
08/24/2006US20060189645 Novel 6-phenylphenantridines
08/24/2006US20060189630 Mitotic kinesin inhibitors
08/24/2006US20060189629 N-(2-morpholin-4-ylethyl)-1-(4-{[4-(trifluoromethoxy)benzyl]oxy}phenyl)-1H -benzimidazole-5-carboxamide; c-Kit proto-oncogene (stem cell factor receptor) anhibitor; tyrosine kinase inhibitor; antiproliferative, anticarcinogenic agent;
08/24/2006US20060189628 Compounds useful as chemokine receptor antagonists
08/24/2006US20060189622 Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations
08/24/2006US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4)
08/24/2006US20060189593 Aryl spirohydantoin cgrp receptor antagonists
08/24/2006US20060189591 Five-membered heterocyclic derivative
08/24/2006US20060189577 Tyrosine kinase inhibitors
08/24/2006US20060189484 Pyridone compounds useful for producing pyridine compounds
08/24/2006US20060186796 Compound, charge transporting material and organic electroluminescent element
08/24/2006DE19639859B4 1-Arylpyrazole, Zusammensetzungen, besonders giftige Köder zur Schädlingsbekämpfung 1 arylpyrazoles compositions, particularly toxic bait for pest control
08/24/2006CA2598489A1 Piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598460A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598459A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity
08/24/2006CA2598458A1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598457A1 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/24/2006CA2598456A1 Heterocyclic substituted piperazines with cxcr3 antagonist activity
08/24/2006CA2598423A1 Antibacterial piperidine derivatives
08/24/2006CA2598076A1 Chemical compounds
08/24/2006CA2597896A1 1h-imidazole derivatives as cannabinoid cb2 receptor modulators
08/24/2006CA2596522A1 3,4-dihydro-1h-isoquinoline-2-carboxylic acid 5-aminopyridin-2-yl esters
08/24/2006CA2596015A1 Fused heterocyclic compounds useful as inhibitors of histone deacetylase
08/24/2006CA2595936A1 Substituted pyrazoles as modulators of chemokine receptors
08/23/2006EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists
08/23/2006EP1693365A1 Inhibitors of dipeptidyl peptidase IV
08/23/2006EP1692502A2 Use of the lipoxin receptor, fprl1, as a tool for identifying compounds effective in the treatment of pain and inflammation
08/23/2006EP1692129A1 Keto lactam compounds and use thereof
08/23/2006EP1692128A1 Indazole compounds and methods of use thereof as protein kinase inhibitors
08/23/2006EP1692124A1 Biaryl sulfonamides as mmp inhibitors
08/23/2006EP1692116A1 1,2,3-triazole amide derivatives as inhibitors of cytokine production
08/23/2006EP1692114A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
08/23/2006EP1692113A1 Aryl imidazoles and their use as anti-cancer agents
08/23/2006EP1692111A2 Quinolines useful in treating cardiovascular disease
08/23/2006EP1692110A1 Diacylhydrazine derivatives
08/23/2006EP1692109A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
08/23/2006EP1692108A1 Novel herbicides
08/23/2006EP1692099A1 Somatostatine receptor subtype 1 (sstr1) active compounds and their use in therapy
08/23/2006EP1692085A2 Inhibition of fgfr3 and treatment of multiple myeloma
08/23/2006EP1691810A1 Substituted piperazines
08/23/2006EP1691803A1 N-alkyl pyrroles as hmg-coa reductase inhibitors
08/23/2006EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis
08/23/2006EP1438305B1 Arthropodicidal anthranilamides
08/23/2006EP1337529B1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same
08/23/2006EP1324741B1 Method of dyeing keratin-containing fibres
08/23/2006EP1223929B1 Cannabimimetic indole derivatives
08/23/2006EP1027328B1 Substituted anilides
08/23/2006CN1823065A Method for the enantioselective preparation of sulphoxide derivatives
08/23/2006CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders
08/23/2006CN1823063A Quinoline derivatives as phosphodiesterase inhibitors
08/23/2006CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators
08/23/2006CN1823059A Selective D1/dD receptor antagonists for the treatment of obesity and CNS disorders
08/23/2006CN1823058A Process for preparing isomerically pure prodrugs of proton pump inhibitors
08/23/2006CN1823057A Biaryl piperazinyl-pyridine analogues
08/23/2006CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto
08/23/2006CN1823055A Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
08/23/2006CN1823054A Imidazole derivatives ó¾
08/23/2006CN1823048A Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands
08/23/2006CN1823046A Phenyl quinolines and their use as estrogenic agents
08/23/2006CN1823041A 1,4-dihydropyridine and pyridine compounds as calcium channel blockers
08/23/2006CN1823040A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
08/23/2006CN1821241A Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same
08/23/2006CN1821236A Therapeutic heterocyclic compounds
08/23/2006CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
08/23/2006CN1271067C Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce TNF & alpha levels
08/23/2006CN1271054C Urea compounds having muscarinic receptor antagonist activity
08/23/2006CN1271052C Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
08/22/2006US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists
08/22/2006US7094900 N-Aryl-2-oxazolidinones and their derivatives
08/22/2006US7094899 Vitreous form of known bradykinin antagonist
08/22/2006US7094897 Rhodium and iridium complexes
08/22/2006US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate
08/22/2006US7094869 Animal growth regulators
08/22/2006US7094800 pyrrolizinones, e.g., (3S,6R,7aS)-6-amino-5-oxo-hexahydro-pyrrolizine-3-carbonitrile trifluoroacetate, used for reducing blood sugar, treating type 2 diabetes, and treating insulin resistance
08/22/2006US7094791 Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
08/22/2006US7094790 containing a pyrrole ring, e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
08/22/2006US7094784 High affinity ligands for nociceptin receptor ORL-1
08/22/2006US7094781 Sulfamides and their use as endothelin receptor antagonists
08/22/2006US7094780 3-aminoquinazolin-2,4-dione antibacterial agents
08/22/2006US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders.
08/22/2006US7094778 Nervous system disorders; muscular disorders; urogenital disorders; gastrointestinal disorders; repiratory system disorders; antiallergens; side effect reduction
08/22/2006US7094777 5-HT2A receptor ligands
08/22/2006CA2270301C Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for their preparation
08/22/2006CA2257825C New processes for preparing pesticidal intermediates
08/22/2006CA2242102C Quinazoline derivatives as antitumor agents
08/17/2006WO2006086705A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
08/17/2006WO2006086657A1 Process for preparing 2,3-disubstituted indoles
08/17/2006WO2006086068A1 Labeled alpha-4-beta-2 ligands and methods therefor
08/17/2006WO2006085685A1 Pyrazole compound
08/17/2006WO2006085112A1 Anthranilic acid derivatives as hm74a receptor agonists
08/17/2006WO2006084854A2 [1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-s-transferase and nadph quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular
08/17/2006WO2006076646A3 Heteroaryl substituted quinolin-4-ylamine analogues
08/17/2006WO2006060122A9 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase